This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

EHE International Selects Project A.L.S. To Raise Awareness For Brain Disease Epidemic

NEW YORK, April 2, 2013 /PRNewswire/ -- As the leader for research in ALS, the devastating brain disorder also known as Lou Gehrig's disease, Project A.L.S. has been selected by EHE International to raise awareness about ALS and related brain diseases in a 103-square foot window display in Rockefeller Plaza. The interactive Project A.L.S. exhibit debuts today in the major international thoroughfare, and will be available to the public for the month of April.

The participatory exhibit focuses on ALS, Alzheimer's, Parkinson's and the closely related brain diseases that will affect 1 in 25 Americans by the year 2020. Scientists agree that if we can understand and treat ALS, we will have new insight into cures for the range of brain diseases. The display window, donated by EHE International, highlights the growing epidemic of brain disease by literally giving viewers a window into the human brain with information about brain disease and opportunities for visitors to participate in stopping its spread.

"People need to realize that brain disease is going to touch each one of us," said Project A.L.S. President and Co-Founder Meredith Estess. "Project A.L.S. is grateful to EHE International for the opportunity to educate the public on a problem that has grown to an epidemic of devastating proportions."

Throughout the month of April, the state-of-the-art exhibit will provide the opportunity for viewers to learn about, participate in, and donate to life-saving Project A.L.S. research. Visitors will interact with the three-dimensional exhibit via eye-popping design elements, a QR code, and perhaps most dramatically, the stark and stunning facts about the prevalence of brain disease in the 21 st century.

"EHE International is proud to support Project A.L.S. by offering the Rockefeller Plaza window to raise public awareness and education about ALS," said Deborah McKeever, President of EHE International.

Since 1913, EHE International has been the recognized leader in preventive medicine. Its clinical protocols are specifically designed for the early detection of preventable disease and its associated risk factors, supported by robust personal coaching and wellness tools and resources, and its industry leading educational and social engagement platforms. The company is well-known for its corporate-sponsored employee benefit, "EHE & Me," a patient-centered approach to preventive care and life-style management programs specifically designed for integration into self-funded employer-sponsored medical plans.

For more information, contact EHE International, 10 Rockefeller Plaza, 4 th Floor, New York, NY 10020; 212-332-3700; www.EHEandMe.com.

Project A.L.S.™ is a non-profit 501©3 devoted to understanding, treating, and ultimately curing ALS, also known as Lou Gehrig's disease. Founded in 1998 by Jenifer Estess, her family and friends, Project A.L.S. has raised more than $67 million and become the new paradigm for brain disease research. ALS is a devastating neurodegenerative disease that, combined with the closely related Parkinson's and Alzheimer's diseases, is a 21 st century epidemic.  In five years 1 in 25 Americans will be affected with a neurodegenerative disease.

For more information, contact Project A.L.S., 801 Riverside Drive #6G, New York, NY 10032; 212-420-7382; www.projectals.org.

ALS, also known as Lou Gehrig's disease and motor neuron disease, is a fatal neurodegenerative disease that affects adults of all ages. ALS targets large brain cells residing in the brain and along the spinal cord called motor neurons. In ALS, as motor neurons get sick and die, a person progressively loses the ability to move: to walk, speak, swallow, and breathe. ALS is usually fatal within 2-5 years of diagnosis.

SOURCE Project A.L.S.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs